Therefore, we infer that GATA3 may be involved in the progression of NAFLD by regulating the natural immune signalling pathways of the liver and producing a variety of inflammatory and lipid metabolism effector molecules. This evidence concerns the gene GATA3 and metabolic dysfunction-associated steatotic liver disease.